CIK 0001699382
- Non-accelerated filer
- Smaller reporting company
PMV Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PMVP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463218129
- Phone
- +1 609-642-6670
- Business address
- 400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON, NJ, 08540
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-10 | Euclidean Capital LLC 10% owner | Sale | −11,485 | $32.68 | $375K | 2,533,517 |
| 2021-06-10 | Euclidean Capital LLC 10% owner | Sale | −585 | $32.68 | $19K | 129,980 |
| 2021-06-09 | Euclidean Capital LLC 10% owner | Sale | −4,192 | $33.64 | $141K | 483,569 |
| 2021-06-09 | Euclidean Capital LLC 10% owner | Sale | −5,883 | $33.64 | $198K | 678,614 |
| 2021-06-09 | Euclidean Capital LLC 10% owner | Sale | −6,372 | $33.64 | $214K | 734,990 |
| 2021-06-09 | Euclidean Capital LLC 10% owner | Sale | −22,070 | $33.64 | $742K | 2,545,002 |
| 2021-06-09 | Euclidean Capital LLC 10% owner | Sale | −1,121 | $33.64 | $38K | 129,565 |
| 2021-06-08 | Euclidean Capital LLC 10% owner | Sale | −3,355 | $33.38 | $112K | 487,761 |
| 2021-06-08 | Euclidean Capital LLC 10% owner | Sale | −4,708 | $33.38 | $157K | 684,497 |
| 2021-06-08 | Euclidean Capital LLC 10% owner | Sale | −5,101 | $33.38 | $170K | 741,362 |
| 2021-06-08 | Euclidean Capital LLC 10% owner | Sale | −17,664 | $33.38 | $590K | 2,567,072 |
| 2021-06-08 | Euclidean Capital LLC 10% owner | Sale | −896 | $33.38 | $30K | 130,686 |
| 2021-06-07 | Euclidean Capital LLC 10% owner | Sale | −3,291 | $33.62 | $111K | 491,116 |
| 2021-06-07 | Euclidean Capital LLC 10% owner | Sale | −4,564 | $33.62 | $153K | 689,205 |
| 2021-06-07 | Euclidean Capital LLC 10% owner | Sale | −4,946 | $33.62 | $166K | 746,463 |
| 2021-06-07 | Euclidean Capital LLC 10% owner | Sale | −16,901 | $33.62 | $568K | 2,584,736 |
| 2021-06-07 | Euclidean Capital LLC 10% owner | Sale | −1,019 | $33.62 | $34K | 131,582 |
| 2021-06-07 | Alland Leila Chief Medical Officer | Exercise or conversion | +4,000 | $3.90 | $16K | 4,000 |
| 2021-06-07 | Alland Leila Chief Medical Officer | Sale | −2,633 | $33.39 | $88K | 1,367 |
| 2021-06-07 | Alland Leila Chief Medical Officer | Sale | −1,367 | $34.00 | $46K | 0 |
Page 13 of 23 · 457 trades